Close menu




April 12th, 2022 | 18:27 CEST

Ukraine: K+S, Bayer, Ximen Mining - Fertilizer shares against the food disaster!

  • PreciousMetals
  • Agriculture
Photo credits: pixabay.com

Ukraine is one of the leading export nations of wheat worldwide. However, the so-called "granary of Europe" does not primarily supply European countries because the main customers are mainly in Asia and North Africa. The most important destination for Ukrainian wheat in 2020, for example, was Egypt. The largest amount is transported overland to Odessa, where it is shipped. But now Putin has started bombing the important port city. Diesel and fertilizer are becoming scarce, so it is all the more important that there are Western specialists who are trying to secure a supply of food through special deliveries in fertilizer and technology. Where are the opportunities for investors?

time to read: 4 minutes | Author: André Will-Laudien
ISIN: K+S AG NA O.N. | DE000KSAG888 , BAYER AG NA O.N. | DE000BAY0017 , XIMEN MINING | CA98420B2003

Table of contents:


    Ukraine conflict - Food shortages ahead

    The price of wheat reached a new high of around USD 420 per ton in March. The main reason for this is the Russian invasion of Ukraine, the leading producer country. Currently, the "granary of Europe" can no longer sell its export hit. Farmers are sitting on thousands of tons of the last harvest and are only mobile at the risk of their lives. A dramatic supply shortage and subsequent famine, especially in Africa, could be the medium-term consequence. Therefore, the international community is called upon to recultivate land set aside from years of surplus production. Technical equipment and fertilizer are needed for this.

    K+S - The fertilizer rally continues

    The MDAX stock Kali und Salz (K+S) is currently in the front line. In addition to road salt for the expiring winter, the Company produces enormous quantities of potash and phosphorus fertilizers. With the start of the warlike activities, concerns about food producers in the war zones were transferred to direct price gains in the K+S share.

    Now the analysts' buy studies are also piling up. The group from Kassel is benefiting from the high energy prices in the overall good agar environment, said JP Morgan expert Chetan Udeshi in a current sector study. Despite the strong price development of +100% in 2022, he raised his investment recommendation by two notches from "underweight" to "overweight" and increased the target price from EUR 12.50 to EUR 44.50. That leaves the share price little choice but to continue to explode. In the last month alone, it went up by a cumulative 35%.

    Massive supply problems for fertilizers following sanctions against Russia are leading to a real boost in earnings for the potash producer this year. And the environment for Europe's fertilizer producers is likely to remain very positive for the next 2 years, as potash prices are now expected to remain high for a longer period. In addition to Ukraine, the world is also looking at the sanctions that have been imposed on Belarus. Both states have accounted for large quantities of global production of potash, ammonia and urea to date.

    The strong trend in the K+S share continues to argue in favor of a long position. Meanwhile, the woes of some short-sellers are also likely to lead to a huge turnover. The fundamental trend is thus continuing upwards. Presumably, K+S is now experiencing two special profit years. Therefore, the trick will be to recognize the upper turning point in time after the Ukraine crisis.

    Ximen Mining - Gold could provide the next refuge

    If, in addition, the warlike activities bring instability to the international payment systems, investors will turn their attention back to precious metals. Gold was able to develop positive sentiment and make a clean turnaround last week. It landed back in the USD 1,945 to USD 1,965 resistance zone after the recent corrections around USD 1,890. With a dynamic breakout, it could now technically go back up to the USD 1,980 to USD 2,015 zone. It is worth paying close attention here because the nervousness in the markets remains immanent.

    Canadian explorer Ximen Mining Corp. (XIM) owns promising precious metals properties in British Columbia. Specifically, these are the Amelia gold mine and the Brett epithermal gold project and, by option, the Treasure Mountain silver project, which is adjacent to the formerly producing Huldra silver mine. Other claims relate to the Greenwood mining camp, the Kenville mine and other blocks in the Nelson area and near Cranbrook.

    In early April, the Company completed a private placement of 10 million units at CAD 0.15, plus a full warrant at CAD 0.25 for 24 months. The Company will use the net proceeds of just under CAD 1.5 million to pay for exploration of the projects and as general working capital. Initial results from drilling should be announced later this year. The good performance of the precious metals means that the valuation of Ximen's resources in the ground can be steadily increased. The 98.7 million XIM shares currently add up to a market capitalization of CAD 17.7 million. It is a good starting point for further appreciation.

    Bayer - Strong growth expected in the Crop Science segment

    There is no stopping Bayer shares at the moment. Due to the glyphosate scandal and the upheavals surrounding Monsanto, the stock has been trending steadily downward since 2017. However, the zone around EUR 45 offered a good limit for substantial recoveries each time in the last three correction movements. And in the last 2 weeks, there was now a strong breakout on the upside because Monsanto's agricultural division could become attractive in the current environment.

    However, the decisive factor for the good mood was the latest publications on the possible Xarelto successor asundexian. Bayer has made progress in the development of the new anticoagulant. A Phase IIb study showed a lower risk of bleeding in patients with atrial fibrillation and a high risk of stroke compared with the standard drug apixaban. Depending on the evaluation of the details, the pivotal Phase III trial is likely to start this year, a Group spokesman said. According to analyst Alistair Campbell of investment firm Liberum, if approved, the drug could be an even bigger success than the best-selling Xarelto, which generates billions in sales for Bayer every year.

    Analysts were, therefore, optimistic about the DAX share last week because of the expected blockbuster asundexian. JP Morgan, for example, is confident that Bayer shares will rise to EUR 75, with an "overweight" rating. At EUR 90, the UBS price target for the pharmaceutical giant from Leverkusen is even a good deal higher. The share continued to jubilate and is now heading for the EUR 70 mark. Stay invested with a stop at EUR 58.50.


    Due to the impairment of Ukrainian and Belarusian food exports, concerns about the world supply of wheat are constantly increasing. This draws attention to fertilizer and seed manufacturers and crop protection experts. K+S and Bayer have a lot to offer here. In the gold and silver sector, Ximen Mining is preparing to climb the next valuation levels.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by Armin Schulz on October 2nd, 2025 | 07:00 CEST

    Buckle up for the new precious metals era: Barrick Mining, Silver North Resources, and First Majestic Silver in focus

    • Mining
    • Gold
    • Silver
    • PreciousMetals
    • Investments

    The signs are pointing to a new precious metals era. Driven by geopolitical upheaval, persistent inflation, and unprecedented demand from central banks, gold and silver are reaching new record highs. While gold shines as a safe haven, silver is also benefiting from the industrial boom, for example, in solar technology. This unique constellation opens up extraordinary opportunities for investors. Against this backdrop, it is worth taking a closer look at three companies. We analyze industry leader Barrick Mining, the exploration company Silver North, and the gold and silver producer First Majestic Silver.

    Read

    Commented by Stefan Feulner on September 30th, 2025 | 07:30 CEST

    Barrick Mining, Desert Gold, Aura Minerals – Epic rally with no end in sight

    • Mining
    • Gold
    • PreciousMetals
    • Investments

    The price of gold has once again reached a new all-time high, amid a global environment fraught with uncertainty. Driven by geopolitical tensions, simmering inflation fears, and record-high debt levels in many countries, the precious metal continues to take center stage. Central banks are buying more gold than they have in decades, while investors are rushing into physical gold, ETFs, and mining stocks. Experts expect another bull run, even beyond the magic mark of USD 4,000 per ounce.

    Read

    Commented by Nico Popp on September 30th, 2025 | 07:25 CEST

    Is the industrial heart of Europe dying? Mercedes-Benz, Porsche, AJN Resources

    • Mining
    • Gold
    • PreciousMetals
    • Electromobility

    Uncertainty in Germany is greater than ever: Increasingly, companies in the automotive industry are cutting jobs. According to industry experts at EY, around 51,100 jobs were lost in the automotive industry within a year, corresponding to around 7% of all jobs. Companies in other sectors are also making cuts. Most recently, Lufthansa also laid off staff. This bad news is accompanied by a worrying mood of doom and gloom among the German population – especially in the traditionally wealthy southwest of the country. In this article, we explain how the industrial giants Porsche and Mercedes-Benz are faring and why more and more investors are turning their attention to gold stocks as a result.

    Read